RS56275B1 - Macrocyclic compounds as trk kinase inhibitors - Google Patents

Macrocyclic compounds as trk kinase inhibitors

Info

Publication number
RS56275B1
RS56275B1 RS20170745A RSP20170745A RS56275B1 RS 56275 B1 RS56275 B1 RS 56275B1 RS 20170745 A RS20170745 A RS 20170745A RS P20170745 A RSP20170745 A RS P20170745A RS 56275 B1 RS56275 B1 RS 56275B1
Authority
RS
Serbia
Prior art keywords
kinase inhibitors
macrocyclic compounds
trk kinase
trk
macrocyclic
Prior art date
Application number
RS20170745A
Other languages
Serbian (sr)
Inventor
Steven Wade Andrews
Kevin Ronald Condroski
Julia Haas
Yutong Jiang
Gabrielle R Kolakowski
Jeongbeob Seo
Hong-Woon Yang
Qian Zhao
Original Assignee
Array Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Array Biopharma Inc filed Critical Array Biopharma Inc
Priority claimed from EP15150036.0A external-priority patent/EP2918588B1/en
Publication of RS56275B1 publication Critical patent/RS56275B1/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
RS20170745A 2010-05-20 2011-05-13 Macrocyclic compounds as trk kinase inhibitors RS56275B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34676710P 2010-05-20 2010-05-20
US201061426716P 2010-12-23 2010-12-23
EP15150036.0A EP2918588B1 (en) 2010-05-20 2011-05-13 Macrocyclic compounds as TRK kinase inhibitors

Publications (1)

Publication Number Publication Date
RS56275B1 true RS56275B1 (en) 2017-11-30

Family

ID=55700963

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20170745A RS56275B1 (en) 2010-05-20 2011-05-13 Macrocyclic compounds as trk kinase inhibitors

Country Status (4)

Country Link
ME (1) ME02808B (en)
NZ (1) NZ703512A (en)
RS (1) RS56275B1 (en)
UA (1) UA110701C2 (en)

Also Published As

Publication number Publication date
ME02808B (en) 2018-01-20
UA110701C2 (en) 2016-02-10
NZ703512A (en) 2016-08-26

Similar Documents

Publication Publication Date Title
IL257104B (en) Macrocyclic compounds as trk kinase inhibitors
HK1218758A1 (en) Compounds as c-met kinase inhibitors c-met
ZA201309128B (en) Macrocyclic compounds as protein kinase inhibitors
HK1192247A1 (en) Heterocyclic compounds as kinase inhibitors
EP2552208A4 (en) Imidazolyl-imidazoles as kinase inhibitors
ZA201301951B (en) Benzimidazole derivatives as p13 kinase inhibitors
EP2552211A4 (en) Indazolyl-pyrimidines as kinase inhibitors
EP2552214A4 (en) Pyrazolyl-pyrimidines as kinase inhibitors
IL221823A (en) Piperidin-4-yl-azetidine derivatives as jak1 inhibitors
IL228103A0 (en) Amino-quinolines as kinase inhibitors
HK1182327A1 (en) Solid dispersions containing kinase inhibitors
GB201009731D0 (en) Kinase inhibitors
EP2563125A4 (en) Azaindoles as janus kinase inhibitors
EP2685992A4 (en) Amino-quinolines as kinase inhibitors
IL220701A0 (en) Tricyclic compounds for use as kinase inhibitors
IL223131A0 (en) Heterocyclic compounds as janus kinase inhibitors
EP2611806A4 (en) Deuterium-enriched heterocyclic compounds as kinase inhibitors
EP2531197A4 (en) Solid state forms of macrocyclic kinase inhibitors
PL2646448T3 (en) Macrocyclic kinase inhibitors
RS56275B1 (en) Macrocyclic compounds as trk kinase inhibitors
GB201009730D0 (en) Kinase inhibitor compounds